CMTTdb: the cancer molecular targeted therapy database
文献类型:期刊论文
作者 | Bai, Xue1,2,3; Yang, Xiaobo1,2; Wu, Liangcai1,2,4,5; Zuo, Bangyou1; Lin, Jianzhen1; Wang, Shanshan1; Bian, Jin1; Sang, Xinting1; He, Yungang2; Yang, Zhen1,2 |
刊名 | ANNALS OF TRANSLATIONAL MEDICINE
![]() |
出版日期 | 2019-11-01 |
卷号 | 7期号:22页码:7 |
关键词 | Molecular-targeted therapy clinical trial cancer database |
ISSN号 | 2305-5839 |
DOI | 10.21037/atm.2019.10.23 |
英文摘要 | Background: The cancer molecular targeted therapy has achieved unprecedented progress in the past decade and is thought to be the most promising direction for cancer treatment in future. As the fast growing of the clinical trials of targeted anticancer agents for different cancer types, it is critical to collect and integrate such information to guide clinical practice. Methods: We constructed the Cancer Molecular Targeted Therapy database (CMTTdb) to store and retrieve molecular targeted therapy data about randomized clinical trials (RCTs) of targeted agents and also accompanied targets, biomarkers, targeted cancer subtypes, etc. Results: Different with some existing resources, CMTTdb particularly focuses on clinical application of the trails. Design of the trails, such as treatment modalities (monotherapy or combination with other therapies), as well as results on clinical efficacy parameters, adverse events are also collected. In this current version, CMTTdb contains data for 1,088 clinical trials which cover 165 agents, 80 targets, 15 cancer types (95 molecular subtypes and 56 histological or cytological subtypes) from public literatures. This database is freely available at http://www.biosino.org/CMTTdb. A user-friendly web interface was designed so that these data can be easily retrieved. Conclusions: CMTTdb will be a valuable source for providing access to information of clinical trials on the rapidly growing number of novel targeted agent and be useful in guiding oncologists for the optimization of the therapy strategy for cancer treatment. |
资助项目 | International Science and Technology Cooperation Projects[2016YFE0107100] ; International Science and Technology Cooperation Projects[2015DFA30650] ; CAMS Innovation Fund for Medical Science (CIFMS)[2017-I2M-4-003] ; CAMS Innovation Fund for Medical Science (CIFMS)[2018-I2M-3-001] ; Beijing Natural Science Foundation[L172055] ; Beijing Natural Science Foundation[7192158] ; Fundamental Research Funds for the Central Universities[3332018032] ; National Ten-thousand Talent Program of the Chinese Academy of Sciences[2016252] ; Youth Innovation Promotion Association of the Chinese Academy of Sciences[2016252] ; Youth foundation of the national natural science foundation of China[81902620] ; Youth foundation of the national natural science foundation of China[81902353] |
WOS研究方向 | Oncology ; Research & Experimental Medicine |
语种 | 英语 |
WOS记录号 | WOS:000500459400057 |
出版者 | AME PUBL CO |
源URL | [http://119.78.100.204/handle/2XEOYT63/14962] ![]() |
专题 | 中国科学院计算技术研究所期刊论文_英文 |
通讯作者 | Yang, Zhen; Zhao, Haitao |
作者单位 | 1.Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Liver Surg, Beijing 100730, Peoples R China 2.Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China 3.Northern Med Univ, Clin Coll 1, Nanfang Hosp, Dept Radiol, Guangzhou 510515, Guangdong, Peoples R China 4.Chinese Acad Sci, Inst Comp Technol, Key Lab Intelligent Informat Proc, Beijing 100190, Peoples R China 5.Fudan Univ, Obstet & Gynecol Hosp, Dept Obstet & Gynecol, Shanghai 200090, Peoples R China |
推荐引用方式 GB/T 7714 | Bai, Xue,Yang, Xiaobo,Wu, Liangcai,et al. CMTTdb: the cancer molecular targeted therapy database[J]. ANNALS OF TRANSLATIONAL MEDICINE,2019,7(22):7. |
APA | Bai, Xue.,Yang, Xiaobo.,Wu, Liangcai.,Zuo, Bangyou.,Lin, Jianzhen.,...&Zhao, Haitao.(2019).CMTTdb: the cancer molecular targeted therapy database.ANNALS OF TRANSLATIONAL MEDICINE,7(22),7. |
MLA | Bai, Xue,et al."CMTTdb: the cancer molecular targeted therapy database".ANNALS OF TRANSLATIONAL MEDICINE 7.22(2019):7. |
入库方式: OAI收割
来源:计算技术研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。